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Release of cytochrome c from mitochondria is a key initiative step in the apoptotic process, although the mechanisms regulating
permeabilization of the outer mitochondrial membrane and the release of intermembrane space proteins remain controversial. Here, we discuss
possible scenarios of the outer membrane permeabilization. The mechanisms by which the intermembrane space proteins are released from
mitochondria depend presumably on cell type and on the nature of the apoptotic stimulus. The variety of mechanisms that can lead to outer
membrane permeabilization might explain diversities in the response of mitochondria to numerous apoptotic stimuli in different types of cells.
© 2006 Elsevier B.V. All rights reserved.Keywords: Apoptosis; Mitochondria; Cytochrome c; Bcl-2 family; Permeability transition1. Introduction
Apoptosis, an active, gene-regulated form of cell death, is
involved in cell deletion during organogenesis and in the control
of cell proliferation and differentiation in adult tissues, as well
as in the pathogenesis of various diseases [1]. The biochemical
machinery required for apoptotic cell death is constitutively
present in virtually all mammalian cells and can be activated by
a variety of extra- and intracellular signals.
In their seminal paper on apoptosis, Kerr et al. [1] proposed
that this is a nuclear event and that mitochondria are not to be
considered a part of the apoptotic process. The authors wrote that
“the apoptotic body shows closely aggregated but apparently
intact mitochondria of epithelial cell types”. However, “when
apoptotic bodies undergo a process within phagosomes, the
matrix of mitochondria becomes electron-lucent and displays
focal flocculent densities” [1].
Later, indirect evidence appeared pointing to a possible
involvement of mitochondria in apoptosis. In one of the earliest
publications, Bcl-2 protein, which blocks programmed cell
death rather than affecting proliferation, was shown to be local-
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Bcl-2 had a higher mitochondrial membrane potential (Δψ) than
wild-type cells. The increase in Δψ was suggested to be
responsible for the enhanced survival of cells after TNF
challenge [3]. The key role of mitochondria in apoptosis was
further hypothesized by Richter [4]. According to his viewpoint,
uncontrolled production of oxygen radicals, a common step in
many models of apoptosis [5], stimulates Ca2+ release from
mitochondria, followed by Ca2+ cycling. Subsequently, Ca2+
cycling causes mitochondrial uncoupling, drop of Δψ, ATP
depletion, massive disturbance of cellular Ca2+ homeostasis, and
a direct stimulation of Ca2+-dependent endonuclease(s). The
importance of Ca2+ in apoptosis was reviewed in detail recently
[6]. To explain the protective functions of Bcl-2, a model was
proposed in which Bcl-2 regulates an antioxidant pathway at
sites of free radical generation [7], although the detailed
investigation of the location of Bcl-2 revealed that it is localized
not in the inner but in the outer mitochondrial membrane [8].
Currently, it is widely accepted that mitochondria play a key
role in the regulation of apoptosis [9]. Specifically, the release of
different pro-apoptotic proteins that are normally present in the
intermembrane space of these organelles has been observed
during the early stages of apoptotic cell death [10,11]. Among
these proteins is a component of the mitochondrial respiratory
chain, cytochrome c. Once in the cytosol, cytochrome c
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recruitment, processing and activation of pro-caspase-9 in the
presence of dATP or ATP [12]. Caspase-9, in turn, cleaves and
activates pro-caspase-3 and -7; these effector caspases are re-
sponsible for the cleavage of various proteins leading to bio-
chemical and morphological features characteristic of apoptosis
[13].
Mitochondrial outer membrane permeabilization is therefore
considered a key initiative step in the apoptotic process, al-
though the precise mechanisms regulating this event have
remained elusive.
2. Mechanisms of mitochondrial outer membrane
permeabilization
2.1. Induction of mitochondrial permeability transition
There are currently several mechanisms that might explain
the mitochondrial outer membrane permeabilization. The first
pathway, which may be engaged during both necrotic and
apoptotic cell death, involves the induction of mitochondrial
permeability transition (MPT) due to the opening of non-
specific pores in the mitochondrial inner membrane followed by
osmotic swelling of the mitochondrial matrix, mitochondrial
uncoupling, rupture of the mitochondrial outer membrane, and
the release of intermembrane space proteins including cyto-
chrome c [14,15] (Fig. 1, upper left corner).
For a long time, MPT was regarded as the prime mechanism
responsible for the permeabilization of the mitochondrial outer
membrane. However, opening of pores in the inner membrane
would lead to harmful consequences for the cell. If permeability
transition and subsequent uncoupling of mitochondria would
occur in a large subpopulation of the organelles, the
mitochondria would start to actively hydrolyze cytosolic ATP
(uncoupling-stimulated ATPase activity). As a result, the ATP
content would drop causing a perturbation of cytosolic Ca2+
homeostasis and activation of various catabolic enzymes
(proteases, phospholipases, etc). Hence, this model of mito-Fig. 1. Permeabilization of the outer mitochondrial membrane induced by
mitochondrial permeability transition (upper left corner), pro-apoptotic Bcl-2
family proteins (upper right corner), modulation of ionic fluxes (lower left
corner) and hypotonicity (lower right corner).chondrial outer membrane permeabilization may be most
relevant during ischemia–reperfusion injury, or in response to
cytotoxic stimuli resulting in localized mitochondrial Ca2+
overload (for recent review see [16]). However, transient pore
opening might also occur whereby a small fraction of
mitochondria would have open pores at a given time [17]; in
this case, mitochondrial protein release would occur without
observable large-amplitude swelling or drop in membrane
potential of the entire organelle population. This process can be
observed also under normal physiological conditions, especially
in mitochondria located in close proximity to calcium “hot
spots”, microdomains, in which the local concentration of
ionized calcium far exceeds the average concentration measured
throughout the cytosol [18]. This local Ca2+ concentration
might be high enough to induce Ca2+ overload and subsequent
pore opening. Therefore, under the influence of apoptotic stim-
uli the frequency of such spontaneous pore opening and closure
might increase, contributing to translocation of intermembrane
space proteins into the cytosol.
Recent observations have questioned the importance of MPT
for the release of cytochrome c from the mitochondria under
apoptotic conditions. Thus, overexpression of cyclophilin-D, a
component of the MPT pore complex, had opposite effects on
apoptosis and necrosis; whereas NO-induced necrosis was
promoted, NO- and staurosporine-induced apoptosis was inhib-
ited. These findings suggest that MPT leads to cell necrosis, but
argue against its involvement in apoptosis [19]. Similarly, cy-
clophilin-D-deficient cells died normally in response to various
apoptotic stimuli, but were resistant to necrotic cell death induced
by reactive oxygen species and Ca2+ overload. In addition, cy-
clophilin-D-deficient mice showed resistance to ischemia/reper-
fusion-induced cardiac injury. These results suggest that the
cyclophilin-D-dependent MPT regulates some forms of necrotic,
but not apoptotic cell death [20,21].
2.2. Bcl-2 family proteins and mitochondrial outer membrane
permeabilization
Another mechanism of outer membrane permeabilization
involves members of the Bcl-2 family proteins (Fig. 1, upper
right corner). The Bcl-2 family consists of more than 30 proteins,
which can be divided into three subgroups: Bcl-2-like survival
factors, Bax-like death factors, and BH3-only death factors.
Residues from BH1, 2 and 3 form a hydrophobic groove, with
which BH3-only death factors interact through their BH3
domain, whereas the N-terminal BH4 domain stabilizes this
pocket (for a recent review see [22]).
Early indications of the importance of these proteins for the
release of cytochrome c were obtained in 1997, when two groups
independently showed that overexpression of Bcl-2 prevented the
efflux of cytochrome c from the mitochondria in apoptotic cells as
well as the initiation of apoptosis [23,24]. It was concluded that
one possible mechanism by which Bcl-2 can prevent apoptosis is
to block cytochrome c release from mitochondria.
The same year, the ability of Bax to stimulate cytochrome c
release was demonstrated in yeast overexpressing Bax [25] (Fig.
1, upper right corner). It was found that Bax-induced growth
Fig. 2. Involvement of Bcl-2 proteins in regulation of cytochrome c release from
mitochondria.
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chain: (i) a decrease in the amount of cytochrome c oxidase, the
terminal enzyme of the respiratory chain, and (ii) a dramatic
release of cytochrome c into the cytosol. Other components of
the mitochondrial inner membrane (the bc1 complex and F0F1-
ATPase) were unaffected. Coexpression of Bcl-XL almost fully
prevented the effect of Bax [25].
The importance of Bax interaction with mitochondria for the
apoptotic process was shown by Jurgensmeier and colleagues
[26]. Addition of submicromolar amounts of recombinant Bax
protein to isolated mitochondria induced cytochrome c release,
whereas a peptide representing the Bax BH3 domain was
inactive. When added to purified cytosol, neither mitochondria
nor Bax alone induced proteolytic processing and activation of
caspases. In contrast, addition of a combination of Bax and
mitochondria triggered release of cytochrome c from the
mitochondria and induced caspase activation in cytosol. Super-
natants from Bax-treated mitochondria also triggered caspase
processing and activation, while recombinant Bcl-XL protein
abrogated Bax-induced release of cytochrome c from isolated
mitochondria and prevented caspase activation.
Several assumptions were made to explain the ability of Bax
to release cytochrome c from mitochondria. In experiments with
lipid membranes it was shown that Bax forms pores in the lipid
bilayer and triggers the release of liposome-encapsulated car-
boxyfluorescein, which could be blocked by Bcl-2 [27]. Further,
using isolated mitochondria Narita et al. [28] reported that pro-
apoptotic Bcl-2 family proteins, Bax or Bak, can release cyto-
chrome c by interacting with MPT pore components, in
particular the voltage dependent anion channel (VDAC). In ad-
dition to cytochrome c release, Bax and Bak caused mitochon-
drial alterations typical of MPT, such as loss ofΔψ and swelling
of the organelles. All of these changes were Ca2+-dependent and
were prevented by MPT inhibitors— cyclosporin A (CsA) and
bongkrekic acid [28]. Furthermore, antibodies that inhibited
VDAC activity prevented Bax-induced cytochrome c release
and loss of mitochondrial membrane potential [29]. Contrary to
these data, it was demonstrated that an inhibitor of pore opening,
Mg2+, also stimulated cytochrome c release and that other MPT
inhibitors could not block the Mg2+-induced efflux [30]. These
results strongly suggest the existence of two distinct mechan-
isms leading to cytochrome c release, one of which is stimulated
by calcium and inhibited by CsA, while the other is Bax-
dependent, Mg2+-sensitive but CsA-insensitive.
Bax, as well as Bak, were further shown to release cyto-
chrome c in an MPT-independent manner via interaction with
VDAC. VDAC is known to be responsible for most of the
metabolite flux across the mitochondrial outer membrane [31].
However, even in the open state it is not large enough (3 nm) to
allow penetration of cytochrome c (14 kDa). On the other hand,
Bax and Bak stimulated the opening of VDAC incorporated
into liposomes and allowed encapsulated cytochrome c to pass,
and the passage was prevented by Bcl-XL [32]. In contrast to
this report, Rostovtseva and colleagues [33] found no electro-
physiologically detectable interaction between VDAC channels
isolated from mammalian mitochondria and either monomeric
or oligomeric forms of Bax. In contrast, another pro-apoptoticprotein, tBid, proteolytically cleaved by caspase-8, affected the
voltage gating of VDAC by inducing channel closure [33]. The
latter finding seems to be more probable since it is unlikely that
VDAC under any circumstances might form a pore larger that in
its open configuration. The results described above were
obtained using artificial systems – liposomes or planar lipid
membranes. Therefore, although it appears that VDAC plays an
important role in the permeabilization of the outer membrane,
the precise mechanisms of its engagement in the cell death
process is still unclear.
Permeabilization of the outer mitochondrial membrane was
shown to be a prerogative of the oligomeric form of Bax, whereas
monomeric Bax was ineffective [34]. Oligomerization of Bax is a
result of binding to the truncated form of the BH3-domain-only
pro-apoptotic protein Bid [35] (Fig. 2). Hence, it was shown that
tBid, triggers the homo-oligomerization of Bax (or Bak) [36],
resulting in the release of cytochrome c from mitochondria. Cells
lacking both Bax and Bak, but not cells lacking only one of these
proteins, have been found to be resistant to tBid-induced cyto-
chrome c release and apoptosis [37]. Moreover, Bax- and Bak-
deficient cells were also resistant to a variety of apoptotic stimuli
that act through themitochondrial pathway, such as staurosporine,
ultraviolet radiation, growth factor deprivation, etoposide, and the
endoplasmic reticulum stress stimulus thapsigargin. Thus,
activation of a “multidomain” pro-apoptotic Bcl-2 familymember
Bax or Bak, appears to be a predominant gateway to mito-
chondrial release of proteins required for cell death in response to
diverse stimuli.
Different mechanisms of tBid-induced release of cytochrome
c were proposed by Scorrano and colleagues [38]. tBid added to
mouse liver mitochondria stimulated cytochrome c release via
mechanisms that did not require the BH3-domain of tBid, or the
presence of Bak (Bax), but were sensitive to CsA. According to
the authors, tBid induces structural re-arrangement of mito-
chondria; individual cristae become fused and the junctions
between the cristae and the intermembrane space open. The
ability of CsA to block tBid-induced release of cytochrome c
suggested that the MPT pore complex was involved in this
remodeling process. However, the physiological importance of
this pathway is doubtful, since the amount of tBid required for
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two orders of magnitude higher than that required for activation
of the Bax/Bak-mediated pathway [39].
The permeability of the outer mitochondrial membrane is
regulated by the concerted operation of pro- and anti-apoptotic
proteins. Anti-apoptotic proteins, such as Bcl-2, Bcl-XL, Mcl-1,
and Bcl-w interact with the pro-apoptotic proteins, Bax and Bak,
thereby preventing their oligomerization. For instance, Mcl-1
suppresses the pore forming activity of Bak by the formation of
complexes with this pro-apoptotic protein [40]. This type of
regulation is quite specific, for example, Bak can be bound by
both Mcl-1 and Bcl-XL, but not by Bcl-2 or Bcl-w [41].
Suppression of Bax pro-apoptotic activity was also shown to
occur via formation of complexes with the DNA repair factor
Ku70. After apoptosis induction Ku70 becomes acetylated at
particular lysine residues, causing dissociation of Bax [42].
Disturbance of the balance between anti- and pro-apoptotic
Bcl-2 family members in favor of the latter can proceed by
mechanisms involving BH3-only proteins that bind to and
occupy the anti-apoptotic proteins, thereby liberating Bax and
Bak. For example, the BH3-only proteins PUMA and NOXA,
which are expressed in a p53-dependent manner upon DNA
damage, were shown to cause outer membrane permeabilization
[43,44]. Co-immunoprecipitation studies showed that NOXA
binds to Bcl-2 and Bcl-XL, depending on a functional BH3
motif of NOXA, but not to Bax [44]. Interestingly, cytosolic p53
cannot only induce PUMA and NOXA, but also directly ac-
tivate Bax and thereby cause permeabilization of the mitochon-
drial outer membrane [45], although the precise mechanism of
this activation is still obscure.
Multiple mechanisms of cytochrome c release can co-exist
within onemodel of cell death. Thus, arsenic-induced cytochrome
c release triggered by low (up to 50 μM) doses of As2O3 was
found to beBax/Bak-dependent and hence, completely blocked in
Bax/Bak double knockout mouse embryonic fibroblasts. How-
ever, at higher arsenic concentrations (above 200 μM) cyto-
chrome c release was caused by a direct effect of the toxicant on
mitochondria resulting in MPT induction, which occurred to a
similar extent in both wild-type cells and cells lacking Bax and
Bak [46].
Bcl-2 family proteins do not only regulate the permeabiliza-
tion of the mitochondrial outer membrane via formation of
pores, but can also modulate MPT induction. Thus, the presence
of a higher level of Bcl-2 protein in mitochondria of Zajdela
hepatoma was the cause of a delay in MPT induction as
compared to liver mitochondria [47]. Conversely, it has been
demonstrated that cell death resulting from Bax overexpression
can occur via induction of MPT, since it was prevented by
inhibition of the MPT with CsA in combination with the phos-
pholipase A2 inhibitor aristolochic acid [48]. Inclusion of
recombinant oligomeric Bax in the incubation buffer markedly
stimulated MPT induction [49].
Cytochrome c is normally bound to the inner mitochondrial
membrane by an association with the anionic phospholipid
cardiolipin, where it can reversibly interact with complexes III
and IV of the respiratory chain. Because of this association, it
seems that dissociation of cytochrome c from cardiolipin mightbe a critical first step for cytochrome c release into the cytosol
and activation of the caspase cascade [50]. It turned out that
simple permeabilization of the mitochondrial outer membrane
by oligomeric Bax is insufficient for cytochrome c release, and
that peroxidation of cardiolipin is an essential step in order to
mobilize cytochrome c from the IMM [51]. Based on these
results we hypothesized that in apoptosis cytochrome c release
occurs by a two-step process, first involving the detachment of
this protein from the inner membrane, followed by permeabi-
lization of the outer membrane and the release of cytochrome c
into the extramitochondrial milieu. These findings indicate that
cardiolipin plays an important role not only in the maintenance
of the structure and functions of the respiratory chain, but also in
the retention of cytochrome c within the intermembrane space.
Selective peroxidation of the unique mitochondrial phos-
pholipid cardiolipin was recently shown by Kagan and
colleagues to precede cytochrome c release [52]. The authors
demonstrated that a pool of cardiolipin-bound mitochondrial
cytochrome c can catalyze cardiolipin peroxidation, which fa-
cilitates the detachment of cytochrome c from the outer surface
of the inner mitochondrial membrane and its subsequent release
into the cytoplasm through pores in the outer membrane. The
peroxidase function of the cardiolipin-cytochrome c complex is
compatible with the proposed two-step mechanism of cyto-
chrome c release and provides a plausible explanation for the
protective effects reported for multiple mitochondrial antioxi-
dant enzymes.
In addition to the mitochondrial respiratory chain, one of the
possible sources for reactive oxygen species (ROS) in mito-
chondria might be p66Shs protein, a redox enzyme that utilizes
reducing equivalents of the mitochondrial electron transfer
chain through the oxidation of cytochrome c [53]. Redox-
defective mutants of p66Shc are unable to induce mitochondrial
ROS generation and swelling in vitro or to mediate mitochon-
drial apoptosis in vivo. Interestingly, a fraction of this cytosolic
enzyme localizes within mitochondria where it forms a complex
with mitochondrial Hsp70. Upon stimulation of apoptosis,
dissociation of this complex occurs, followed by the release of
monomeric p66Src and its interaction with cytochrome c to
generate hydrogen peroxide.
In contrast to MPT-induced cytochrome c release, the release
mediated by Bcl-2 family proteins occurs without apparent
alterations of ultrastructure and main mitochondrial functions,
even when the loss of cytochrome c was almost complete [54].
Apparently, under these circumstances, mitochondrialΔψ could
be maintained via hydrolysis of glycolytic ATP, since the severe
loss of cytochrome c should have blocked mitochondrial
respiration.
2.3. Volume-dependent, MPT-independent mechanisms of
cytochrome c release
Volume-dependent mechanisms of cytochrome c release
from the intermembrane space are based on mitochondrial
swelling, leading to permeabilization of the mitochondrial outer
membrane. The swelling that is observed in these cases is most
often MPT-dependent. Opening of MPT pores requires at least
643V. Gogvadze et al. / Biochimica et Biophysica Acta 1757 (2006) 639–647two obligatory components, namely high intramitochondrial
Ca2+ and significantly lowered ATP levels (reviewed in [55]).
Induction of MPT leads, in turn, to a disruption of Ca2+ and ATP
homoeostasis. Thus, one might expect that during apoptosis the
probability of persistent pore openingmust be relatively low, and
that MPT-independent volume changes could play an important
role in the regulation of cytochrome c release. In contrast to
MPT, a relatively modest increase in mitochondrial volume
stimulated either by alteration of ion transporting systems or by
osmotic changes should not have any major effects on
mitochondrial function or intracellular ATP level if the integrity
of the inner mitochondrial membrane is unaffected.
For example, stimulation of K+ influx by low (nanomolar)
concentrations of the K+-selective ionophore valinomycin
induced swelling, which was accompanied by cytochrome c
release [56]. The MPT inhibitor CsA had no effect on vali-
nomycin-induced swelling and cytochrome c release, indicating
that valinomycin-induced release of cytochrome c occurs
without MPT and these organelles maintain their membrane
integrity. Moreover, because of the low amplitude swelling that
was observed in the presence of valinomycin the amount of
cytochrome c released from mitochondria was markedly lower
than that during MPT induction. In addition to cytochrome c,
mitochondrial swelling triggered the release of adenylate kinase-
2 (AK-2). Importantly, the concentration of valinomycin (2 nM)
was not sufficient to induce a complete depolarization of
mitochondria. Mitochondria still maintained controlled respira-
tion; however, due to the partial loss of cytochrome c, the rates of
state 3 and uncoupled respiration were suppressed. Finally,
valinomycin stimulated state 4 respiration that resulted in a
decrease of the respiratory control ratio.
Similar effects can be achieved via modulation of major K+
transporting systems. In 1981, Mironova and colleagues isolated
a protein from beef heart mitochondria, which induced
potassium conductivity when incorporated into bilayer lipid
membrane [57]. The K+ uniporter turned out to be a mito-
chondrial ATP-dependent potassium (KATP) channel [58].
Mitochondrial potassium transport, represented by uptake via
the K+-uniporter (KATP channel) and efflux via the K+/H+
exchanger [59], controls mitochondrial volume [60]. Net uptake
of potassium leads to a volume increase, which might be
sufficient to make the outer membrane permeable to cytochrome
c (Fig. 1, lower left corner). Indeed, Garlid and colleagues have
shown that opening mitochondrial KATP channels has little
direct effect on respiration, membrane potential, or Ca2+ uptake
but has important effects on matrix and intermembrane space
volumes. [61]. Moreover, as it has been demonstrated by
Holmuhamedov and colleagues, K+ channel openers, cromaka-
lim and pinacidil, increased matrix volume and released
mitochondrial proteins, cytochrome c and AK-2 [62]. Further-
more, Garlid and co-workers clearly demonstrated that increas-
ing K+ influx and stimulation of K+ cycling makes the outer
mitochondrial membrane permeable to cytochrome c. [63].
Recently, stimulation of potassium uptake by mitochondria
via a K+-uniporter was shown in HL-60 cells undergoing
etoposide-induced apoptosis [64]. As a result, mitochondrial
swelling was initiated leading to the release of cytochrome c.Although MPTwas also observed [65], the authors stated that it
was not the primary cause of mitochondrial swelling. Inter-
estingly, K+ uptake and swelling of mitochondria were blocked
by Bcl-2 overexpression. As a result, cytochrome c release was
reduced, and apoptosis was delayed. In contrast, tBid stimulated
potassium uptake and subsequent cytochrome c release.
Analysis of the mechanism by which Bcl-2 normalized the
mitochondrial volume revealed that this protein upregulated the
mitochondrial potassium efflux mechanism — the K+/H+ ex-
changer. Consequently, the net influx of K+ decreased, and
mitochondrial volume did not change [65].
It should be mentioned, however, that the existence of the
mitochondrial K+-ATP channel has been questioned recently,
although the authors do not rule out the presence of other
mitochondrial K+ channels [66]. Studies of mitochondrial
volume regulation led Halestrap and coworkers to suggest that
Ca2+-dependent increase in matrix volume is caused by K+
entry, and that the responsible protein is adenine nucleotide
translocase, which, under normal conditions, translocates ATP
and ADP across the inner mitochondrial membrane [67–69].
Apparently, low (micromolar) concentrations of Ca2+ stimulate
formation of pyrophosphate, which displaces adenine nucleo-
tides from adenine nucleotide translocase and converts the latter
into a potassium channel.
Another mechanism potentially involved in mitochondrial
swelling and cytochrome c release could be alteration of
osmolarity in the cytoplasm (Fig. 1, lower right corner). Loss of
K+, the major osmotically active intracellular component,
which is present in the cytosol at high concentration
(140 mM), from cells is often observed during apoptosis [70–
73]. The overall decrease in intracellular potassium may result
not only from the efflux of intracellular potassium, but also from
the inhibition of potassium uptake due to suppression of the
Na+/K+-ATPase. Recently, Na+/K+-ATPase inhibition was
shown to occur during both anti-Fas- and glucocorticoid-in-
duced apoptosis of lymphoid cells [74,75].
The efflux of K+ brings about compensatory efflux of water in
order tomaintain physiologicalK+ concentration in cytoplasm.As
a result cells undergo shrinkage,which is a characteristic feature of
apoptosis. The question is whether water efflux is adequate for
restoration of physiological K+ concentration.
Several studies clearly indicate that in apoptotic cell the
concentration (not only content) of potassium decreases
markedly [76,77]. In particular, Hughes et al. [77] estimated a
95% loss in K+ content associated with only a 33% loss of cell
volume, arguing favorably for a decrease in K+ concentration
indicating that compensatory mechanisms do not restore
completely the initial tonicity.
In model experiments with isolated rat liver mitochondria,
transient mild hypotonicity (1 min, 100 mM KCl) followed by
restoration of the initial tonicity with concentrated KCl solution,
induced partial release of cytochrome c [56]. This treatment did
not affect main functional parameters of mitochondria, in parti-
cular Ca2+-buffering capacity. However, the amount of Ca2+ that
was needed to induceMPTwas decreased after hypotonic shock.
Thus, the release of cytochrome c may occur via modulation
of mitochondrial volume regardless of the mechanisms leading
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release of cytochrome c, under these circumstances the mito-
chondria remain intact and capable of maintaining their mem-
brane potential.
2.4. Caspase-2-mediated release of cytochrome c
Permeabilization of the outer mitochondrial membrane and
subsequent release of cytochrome c are normally involved in
the activation of downstream caspases. However, in some
models of apoptosis, inhibition of caspase activity prevented
mitochondrial changes in apoptotic cells [78]. Investigation of
the mechanisms of the outer membrane permeabilization
raised questions as to whether caspases can affect mitochon-
drial function or even promote the outer membrane permea-
bilization. It has been shown in UV-irradiated or
staurosporine-treated cells that if caspases are inhibited,
mitochondrial protein import function is retained, despite the
loss of cytochrome c. Thus, it appears that Bid and Bax act
only on the outer membrane, and that lesions in the
mitochondrial inner membrane occurring during apoptosis
are secondary, caspase-dependent events [78].
Involvement of caspases in mitochondrial dysfunction
during apoptosis was analyzed by Green and colleagues [79].
Addition of recombinant caspase-3 following limited permea-
bilization of the mitochondrial outer membrane by Bax/Bak
resulted in inhibition of complexes I and II, loss of Δψ,
increased production of ROS, and disruption of mitochondrial
morphology. It was concluded that after outer membrane
permeabilization and cytochrome c release, activated caspases
might target the permeabilized mitochondria. This alters
mitochondrial functional activity (loss of Δψ) and generates
ROS through effects of caspases on complex I and II in the
electron transport chain [79]. All these events were attenuated in
cells expressing a caspase-resistant p75 mutant. The authors
suggested that the target for caspase-3 is the 75-kDa subunit of
complex I of the electron transport chain, although the
expression of noncleavable p75D255A produced only partial
protection from loss of Δψ and alteration of mitochondrial
morphology in cells undergoing apoptosis [80]. It is also unclear
how the presence of noncleavable p75D255A in complex I would
protect Complex II of the mitochondrial respiratory chain from
caspase proteolysis.
Recent evidence indicates that caspase-2 can be directly
involved in the release of cytochrome c from mitochondria
in apoptotic cells [81,82]. Caspase-2 was the first cloned
human apoptotic caspase [83], which is activated early in
response to genotoxic stress and can function as an
upstream modulator of the mitochondrial apoptotic pathway.
Recent studies of caspase-2 activation have shown that this
occurs within a multiprotein complex, containing the p53-
inducible protein, PIDD, the adaptor protein, RAIDD, and
possibly additional proteins [84,85]. Caspase-2 as well as
some other caspases have been shown to be associated with
mitochondria [86–88].
DNA damage induced by the chemotherapeutic drug etopo-
side triggers the onset of a series of intracellular events char-acteristic of apoptosis. Among the early changes observed is the
release of cytochrome c from mitochondria. Cells treated with
caspase-2 inhibitor, benzyloxycarbonyl–Val–Asp–Val–Ala–
Asp–fluoromethyl ketone (z-VDVAD-fmk), or stably trans-
fected with pro-caspase-2 antisense, are refractory to cyto-
chrome c release stimulated by etoposide. Apart from inhibiting
cytochrome c release, undermining caspase-2 processing results
in the attenuation of downstream events, including caspase-9
and -3 activation, phosphatidylserine exposure on the cell
surface, and DNA fragmentation. Taken together, these data
suggest that caspase-2 provides an important link between
etoposide-induced DNA damage and the engagement of the
mitochondrial apoptotic pathway [89].
In model experiments with isolated rat liver mitochondria, it
has been shown that fully processed caspase-2 stimulates
mitochondrial release of cytochrome c and Smac/DIABLO, but
not AIF. Importantly, these events occurred independently of
several Bcl-2 family proteins, including Bax, Bak and Bcl-2
[90], although the presence of Bcl-2 family proteins was
reported to be necessary for caspase-2-mediated cytochrome c
release in another study [91].
Inactivation experiments revealed that the proteolytic
activity of caspase-2 was not required for the cytochrome c
release. Combined, these data suggest that caspase-2 retains a
unique ability to engage directly the mitochondrial apoptotic
pathway, an effect that requires processing of the zymogen but
not the associated catalytic activity [90]. Recent experiments
using permeabilized cells, isolated mitochondria, and protein-
free liposomes, revealed that this effect is direct and depends
neither on the presence or cleavage of other proteins nor on a
specific phospholipid composition of the liposomal membrane
[92]. Interestingly, caspase-2 was also shown to disrupt the
interaction of cytochrome c with anionic phospholipids, notably
cardiolipin, and thereby enhance the release of the hemoprotein
caused by treatment of mitochondria with digitonin or the
proapoptotic protein Bax [92].
2.5. Concluding remarks
The permeabilization of the mitochondrial outer membrane
and release of intermembrane space proteins such as
cytochrome c, Smac/DIABLO, and AIF, are unequivocally
one of the central events in apoptosis. The mechanism by
which these intermembrane space proteins are released from
mitochondria depends presumably on cell type and the nature
of stimuli. The existence of several different mechanisms of
cytochrome c release might explain diversities in the response
of mitochondria to numerous apoptotic stimuli in different
types of cells.
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